Pattern of Malignant Tumors Observed in a University Hospital: A Retrospective Analysis
May 1998, Volume 48, Issue 5
Editorial
Tumour marker is a molecular moiety; the presence, the absence, or a quantitative change in its status marks the presence or absence of a malignant disease or a change in tumour burden. They are of interest being raw material of refined diagnosis and rational therapy. Historically
ORIGINAL ARTICLES
Role of Serum Angiotensin Converting Enzyme in Sarcoidosis
Aysha H. Khan , et al
Doxorubicin Cardiomyopathy in Lung Cancer Patients
Tariq Siddiqui , et al
RESEARCH ARTICLES
IN THIS ISSUE
Family Medicine Corner
WEB Review World Health Organization http://www.who.ch
Syed Mabmood Ali Shah , et al
Letter to the Editor
Meetings and Seminars
REVIEW ARTICLES
Review Articles
Factors Influencing Prognosis in Renal Cell Carcinoma
M. Hammad Ather , et al
CASE REPORTS
Primary Spinal T-Cell Rich B-Cell Lymphoma: A Case Report
Suhail Muzaffar , et al
Perianal Basal Cell Carcinoma - Report of Two Cases
Simeen Ber Rahman , et al
STUDENTS' CORNER
Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: